Search Results

Filter
  • 1-10 of  1,591 results for ""Suppressor of Cytokine Signaling 1 Protein""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The Role of miR-150-5p/SOCS1 Pathway in Arsenic-Induced Pyroptosis of LX-2 Cells.

  • Authors : Zhang M; Department of Preventive Medicine, College of Medicine, Shihezi University, Shihezi, 832000, China.; Key Laboratory for Prevention and Control of Emerging Infectious Diseases and Public Health Security, the Xinjiang Production and Construction Corps, Shihezi, China.

Subjects: Pyroptosis*/Pyroptosis*/Pyroptosis*/drug effects ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism ; MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics

  • Source: Biological trace element research [Biol Trace Elem Res] 2025 Feb; Vol. 203 (2), pp. 822-834. Date of Electronic Publication: 2024 Apr 30.Publisher: Humana Press Country of Publication: United States NLM ID: 7911509 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

NSUN2 knockdown inhibits macrophage infiltration in diabetic nephropathy via reducing N5-methylcytosine methylation of SOCS1.

  • Authors : Wang R; Department of Laboratory Medcine, The 305 Hospital of PLA, No.13 Wenjin Street, Xicheng District, Beijing, 100017, China.; Qu J

Subjects: Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/metabolism ; Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/genetics ; Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/metabolism

  • Source: International urology and nephrology [Int Urol Nephrol] 2025 Feb; Vol. 57 (2), pp. 643-653. Date of Electronic Publication: 2024 Oct 09.Publisher: Springer Country of Publication: Netherlands NLM ID: 0262521 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Design and functional studies of xylene-based cyclic mimetics of SOCS1 protein.

  • Authors : Cugudda A; Department of Pharmacy - University of Naples Federico II, 80131, Naples, Italy.; La Manna S

Subjects: Drug Design* ; Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/chemistry ; Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/drug effects

  • Source: European journal of medicinal chemistry [Eur J Med Chem] 2025 Jan 15; Vol. 282, pp. 117107. Date of Electronic Publication: 2024 Nov 25.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

IFN-τ Maintains Immune Tolerance by Promoting M2 Macrophage Polarization via Modulation of Bta-miR-30b-5p in Early Uterine Pregnancy in Dairy Cows.

  • Authors : Feng X; Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China.; Yang C

Subjects: Macrophages*/Macrophages*/Macrophages*/metabolism ; Macrophages*/Macrophages*/Macrophages*/immunology ; Interferon Type I*/Interferon Type I*/Interferon Type I*/metabolism

  • Source: Cells [Cells] 2025 Jan 10; Vol. 14 (2). Date of Electronic Publication: 2025 Jan 10.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

×
Academic Journal

Methyltransferase METTL3 regulates neuropathic pain through m6A methylation modification of SOCS1.

  • Authors : Wu L; Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, China; The First Clinical College of Guangxi University of Traditional Chinese Medicine, Nanning, China.

Subjects: Methyltransferases*/Methyltransferases*/Methyltransferases*/metabolism ; Methyltransferases*/Methyltransferases*/Methyltransferases*/genetics ; Neuralgia*/Neuralgia*/Neuralgia*/metabolism

  • Source: Neuropharmacology [Neuropharmacology] 2024 Dec 15; Vol. 261, pp. 110176. Date of Electronic Publication: 2024 Sep 30.Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

SOCS1: A potential diagnostic and prognostic marker for aggressive gliomas and a new target for immunotherapy.

  • Authors : Gu C; The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.; Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China.

Subjects: Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/genetics ; Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/metabolism ; Glioma*/Glioma*/Glioma*/therapy

  • Source: Medicine [Medicine (Baltimore)] 2024 Dec 06; Vol. 103 (49), pp. e40632.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A peptide mimic of SOCS1 modulates equine peripheral immune cells in vitro and ocular effector functions in vivo : implications for recurrent uveitis.

  • Authors : Stafford LS; Microbiology and Cell Science, Institute of Food and Agricultural Science, University of Florida, Gainesville, FL, United States.; Plummer CE

Subjects: Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/metabolism ; Leukocytes, Mononuclear*/Leukocytes, Mononuclear*/Leukocytes, Mononuclear*/immunology ; Leukocytes, Mononuclear*/Leukocytes, Mononuclear*/Leukocytes, Mononuclear*/drug effects

  • Source: Frontiers in immunology [Front Immunol] 2025 Jan 10; Vol. 15, pp. 1513157. Date of Electronic Publication: 2025 Jan 10 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Inflammatory factor-mediated miR-155/SOCS1 signaling axis leads to Treg impairment in systemic lupus erythematosus.

  • Authors : Yu J; Department of Rheumatology, The First People's Hospital of Yunnan Province, The Affliated Hospital of Kunming University of Science and Technology, Kunming 650032, Yunnan, China.; Mei J

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism ; Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/genetics

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 Nov 15; Vol. 141, pp. 113013. Date of Electronic Publication: 2024 Aug 30.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

SOCS1 Inhibits IL-6-Induced CD155 Overexpression in Lung Adenocarcinoma.

  • Authors : Marroquin-Muciño M; Laboratorio de Cancer Pulmonar, Departamento de Enfermedades Cronico-Degenerativas, Instituto Nacional de Enfermedades Respiratorias 'Ismael Cosio Villegas', Mexico City 14080, Mexico.; Laboratorio de Quimioterapia Experimental, Departamento de Bioquimica, Escuela Nacional de Ciencias Biologicas, Instituto Politecnico Nacional, Mexico City 11340, Mexico.

Subjects: Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/metabolism ; Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/Suppressor of Cytokine Signaling 1 Protein*/genetics ; Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/Adenocarcinoma of Lung*/genetics

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Nov 12; Vol. 25 (22). Date of Electronic Publication: 2024 Nov 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

GDF15 attenuates sepsis-induced myocardial dysfunction by inhibiting cardiomyocytes ferroptosis via the SOCS1/GPX4 signaling pathway.

  • Authors : Li X; College of Life Sciences, Northwest University, Xi'an, 710069, China; Department of Cardiovascular Surgery, Xijing Hospital, The Air Force Medical University, Xi'an, 710032, China.

Subjects: Ferroptosis*/Ferroptosis*/Ferroptosis*/drug effects ; Growth Differentiation Factor 15*/Growth Differentiation Factor 15*/Growth Differentiation Factor 15*/metabolism ; Growth Differentiation Factor 15*/Growth Differentiation Factor 15*/Growth Differentiation Factor 15*/genetics

  • Source: European journal of pharmacology [Eur J Pharmacol] 2024 Nov 05; Vol. 982, pp. 176894. Date of Electronic Publication: 2024 Aug 13.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  1,591 results for ""Suppressor of Cytokine Signaling 1 Protein""